Immunotherapy has emerged as a groundbreaking approach in treating various types of diseases, particularly cancer. The potential to harness the body's immune system to combat disease has opened new avenues in medical treatment, necessitating a comprehensive understanding for physicians.
Immunotherapy, often referred to as biological therapy, works by boosting or restoring the body's natural defenses against disease. This is accomplished by stimulating the immune system to work harder or smarter, or by providing it with additional components, such as synthetic immune system proteins.
There are several types of immunotherapy including monoclonal antibodies, immune checkpoint inhibitors, cancer vaccines, and non-specific immunotherapies. Each type has a unique mechanism of action, but all aim to enhance the body's immune response against disease.
Immunotherapy has shown significant promise in the field of oncology. It has been effective in treating melanoma, lung cancer, head and neck cancer, bladder cancer, and Hodgkin lymphoma among others. Some immunotherapies have been approved as first-line treatments, while others are used when other treatments have not worked.
Like all treatments, immunotherapy can cause side effects, which can vary from patient to patient. Common side effects include fatigue, cough, nausea, skin rash, and loss of appetite. Physicians must be equipped with strategies to manage these side effects to improve patient comfort and treatment adherence.
Immunotherapy represents a paradigm shift in medical treatment, offering new hope for patients with various diseases. As this field continues to evolve, it is crucial for physicians to stay abreast of the latest developments to provide optimal patient care. Understanding the fundamentals of immunotherapy is the first step in this journey.
1.
Tumor characteristics found to differ for melanomas in children, teens and young adults
2.
Unexplained CAR-T Death; Americans Spurn Sunscreen; Improving Diversity in Trials
3.
"A lot" of aspirin reduces the risk of ovarian cancer, regardless of genetic factors, according to the JAMA study.
4.
Approval in Endometrial Cancer Expanded; Masks at Cancer Centers; NPR Reporter Dies
5.
Is Lenalidomide Resistance in Myeloma Reversible with JAK Inhibition?
1.
Modern Oncology Unveiled with Treatment Innovations and Personalized Cancer Care
2.
Screening for Early Therapy-Related Cancer Susceptibility
3.
Unlocking the Potential of Bicalutamide 50 mg: A Revolutionary New Treatment for Prostate Cancer
4.
Skin-Sparing Mastectomy: Balancing Cancer Control with Cosmetic Results
5.
Reducing Modifiable Childhood Cancer Exposure Risks
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
2.
Targeting Oncologic Drivers with Dacomitinib: Further Discussion on Lung Cancer Treatment
3.
Should We Use DARA Up Front As First-Line Therapy in MM?
4.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- A New Perspective
5.
Importance of Cancer Screening and Early Detection
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation